期刊文献+

A Clinical Study on Global TCM Therapy in Treating Senile Advanced Non-small Cell Lung Cancer 被引量:6

A Clinical Study on Global TCM Therapy in Treating Senile Advanced Non-small Cell Lung Cancer
原文传递
导出
摘要 Objective: To assess the clinical efficacy of global traditional Chinese medicine (TCM) therapy in treating senile advanced non-small cell lung cancer (NSCLC), with the aim of seeking a standardized, rational and economical way to treat advanced NSCLC in old patients. Methods: A retrospective analysis and comparison was carried out in 86 patients with senile advanced NSCLC, 44 treated by global TCM (TCM group) and 42 by chemotherapy (control group) through dynamical observation on related indexes including tumor size, quality of life and the survival time, as well as on the fee for medical service at various time points in the course of the treatment. Results: The changes of tumor size, score of clinical main symptoms and behavior condition (by ZPS scoring), as well as survival rates in the two groups at corresponding time points, were not different significantly (P〉0.05). The mean survival time in the TCM group was 13.20 ± 1.52 months and that in the chemotherapy group was 13.45 ±1.94 months, showing insignificant difference between them. However, the median survival time in the TCM group (12 months) was actually longer than that in the chemotherapy group (9 months, P〈0.05). The mean daily expense and the mean expense (RMB yuan) for each patient in the TCM group were significantly lower than that in the control group, which was 180.73 ±93.21 vs 825.84 ±329.63 for the mean daily expense and 34 077.21 ±14 638.04 vs 58 516.59 ±45 429.76 for the mean expense for each patient (both P〈0.01). Conclusion: Treatment of senile advanced NSCLC with TCM alone has its apparent superiority in stabilizing tumor focus, improving clinical symptoms, elevating quality of life and prolonging the survival time. TCM is also less expensive, making it a good alternative therapeutic approach for this specific group of people. Objective: To assess the clinical efficacy of global traditional Chinese medicine (TCM) therapy in treating senile advanced non-small cell lung cancer (NSCLC), with the aim of seeking a standardized, rational and economical way to treat advanced NSCLC in old patients. Methods: A retrospective analysis and comparison was carried out in 86 patients with senile advanced NSCLC, 44 treated by global TCM (TCM group) and 42 by chemotherapy (control group) through dynamical observation on related indexes including tumor size, quality of life and the survival time, as well as on the fee for medical service at various time points in the course of the treatment. Results: The changes of tumor size, score of clinical main symptoms and behavior condition (by ZPS scoring), as well as survival rates in the two groups at corresponding time points, were not different significantly (P〉0.05). The mean survival time in the TCM group was 13.20 ± 1.52 months and that in the chemotherapy group was 13.45 ±1.94 months, showing insignificant difference between them. However, the median survival time in the TCM group (12 months) was actually longer than that in the chemotherapy group (9 months, P〈0.05). The mean daily expense and the mean expense (RMB yuan) for each patient in the TCM group were significantly lower than that in the control group, which was 180.73 ±93.21 vs 825.84 ±329.63 for the mean daily expense and 34 077.21 ±14 638.04 vs 58 516.59 ±45 429.76 for the mean expense for each patient (both P〈0.01). Conclusion: Treatment of senile advanced NSCLC with TCM alone has its apparent superiority in stabilizing tumor focus, improving clinical symptoms, elevating quality of life and prolonging the survival time. TCM is also less expensive, making it a good alternative therapeutic approach for this specific group of people.
出处 《Chinese Journal of Integrative Medicine》 SCIE CAS 2007年第4期269-274,共6页 中国结合医学杂志(英文版)
关键词 traditional Chinese medicine therapy GLOBAL SENILE advanced non-small cell lung cancer traditional Chinese medicine therapy, global, senile, advanced non-small cell lung cancer
  • 相关文献

参考文献10

  • 1Chinese Medicine Association.Guide of clinical diagnosis and treament[]..2005
  • 2.Evaluation on contemporary oncology Internal therapy regimen[]..1998
  • 3.Oncology of internal medicine[]..2000
  • 4.Lung Cancer[]..2000
  • 5.Integrated traditional Chinese and Western therapy of lung cancer[]..2002
  • 6Gu YQ.Epidemiology and therapy characteristics of senile oncology[].Geriatr Health Care(Chin).2002
  • 7.Theory and practice of multi-subject combination therapy on lung cancer[]..2000
  • 8Ricci S,Antonuzzo A,Galli L,et al.Gemcitabine monotherapy in elderly patients with advanced non-small cell lung cancer:a multicenter phaseⅡstudy[].Lung Cancer.2000
  • 9Hainsworth JD,Burris HA 3rd,Litchy S,et al.Weekly docetaxel in the treatment of elderly pantients with advanced non-small cell lung carcinoma.A Minnie Pearl Cancer Research Network PhaseⅡTrial[].Cancer.2000
  • 10The Elderly Lung Cancer Vinorelbine Italian Study Group.Effects of winorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer[].Journal of the National Cancer Institute.1999

同被引文献61

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部